XML 47 R65.htm IDEA: XBRL DOCUMENT v3.3.0.814
Financial Information for the Company and Its Subsidiaries (Income Statements) (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Aug. 27, 2015
May. 20, 2015
Mar. 03, 2015
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Condensed Financial Statements, Captions [Line Items]              
Net revenue       $ 650,227 $ 502,350 $ 1,862,622 $ 1,040,138
Operating expenses:              
Salaries and benefits       327,532 240,337 950,107 406,539
Supply cost       45,638 41,886 134,012 120,564
Other operating expenses       98,852 81,262 294,424 191,243
Transaction costs       2,107 25,102 5,560 28,681
Depreciation and amortization       24,106 20,838 70,536 37,533
Total operating expenses       498,235 409,425 1,454,639 784,560
Net gain on deconsolidations       9,112 0 5,854 3,411
Equity in earnings of unconsolidated affiliates       4,935 2,158 11,575 3,461
Operating income       166,039 95,083 425,412 262,450
Interest expense, net       30,242 39,054 90,671 52,906
Debt extinguishment costs       0 16,887 0 16,887
Earnings from continuing operations before income taxes       135,797 39,142 334,741 192,657
Income tax expense       37,518 22 76,960 25,802
Net earnings from continuing operations       98,279 39,120 257,781 166,855
Net loss from discontinued operations       0 (1,697) 0 (1,146)
Net earnings       98,279 37,423 257,781 165,709
Less net earnings attributable to noncontrolling interests       55,618 47,257 160,407 139,387
Net earnings (loss) attributable to AmSurg Corp. shareholders       42,661 (9,834) 97,374 26,322
Preferred stock dividends $ (2,300) $ (2,300) $ (2,300) (2,264) (2,239) (6,792) (2,239)
Net earnings (loss) attributable to AmSurg Corp. common shareholders       40,397 (12,073) 90,582 24,083
Amounts attributable to AmSurg Corp. common shareholders:              
Earnings (loss) from continuing operations, net of income tax       40,397 (10,697) 90,582 25,466
Loss from discontinued operations, net of income tax       0 (1,376) 0 (1,383)
Net earnings (loss) attributable to AmSurg Corp. common shareholders       40,397 (12,073) 90,582 24,083
Consolidation, Eliminations [Member]              
Condensed Financial Statements, Captions [Line Items]              
Net revenue       (9,614) (4,803) (27,956) (14,189)
Operating expenses:              
Salaries and benefits       (128) (123) (380) (369)
Supply cost       (20) 0 (54) 0
Other operating expenses       (9,466) (4,680) (27,522) (13,820)
Transaction costs       0 0 0 0
Depreciation and amortization       0 0 0 0
Total operating expenses       (9,614) (4,803) (27,956) (14,189)
Net gain on deconsolidations       0   0 (3,411)
Equity in earnings of unconsolidated affiliates       (155,720) (104,716) (405,306) (308,795)
Operating income       (155,720) (104,716) (405,306) (312,206)
Interest expense, net       0 0 0 0
Debt extinguishment costs         0   0
Earnings from continuing operations before income taxes       (155,720) (104,716) (405,306) (312,206)
Income tax expense       0 0 0 0
Net earnings from continuing operations         (104,716)   (312,206)
Net loss from discontinued operations         0   0
Net earnings       (155,720) (104,716) (405,306) (312,206)
Less net earnings attributable to noncontrolling interests       0 0 0 0
Net earnings (loss) attributable to AmSurg Corp. shareholders       (155,720) (104,716) (405,306) (312,206)
Preferred stock dividends       0 0 0 0
Net earnings (loss) attributable to AmSurg Corp. common shareholders       (155,720) (104,716) (405,306) (312,206)
Amounts attributable to AmSurg Corp. common shareholders:              
Earnings (loss) from continuing operations, net of income tax         (104,716)   (312,206)
Loss from discontinued operations, net of income tax         0   0
Net earnings (loss) attributable to AmSurg Corp. common shareholders       (155,720) (104,716) (405,306) (312,206)
Parent Company [Member]              
Condensed Financial Statements, Captions [Line Items]              
Net revenue       5,975 5,551 20,145 18,042
Operating expenses:              
Salaries and benefits       17,642 14,961 50,796 44,728
Supply cost       0 0 0 0
Other operating expenses       7,054 6,425 19,471 15,440
Transaction costs       270 23,111 862 26,690
Depreciation and amortization       1,017 789 2,907 2,429
Total operating expenses       25,983 45,286 74,036 89,287
Net gain on deconsolidations       0   0 3,411
Equity in earnings of unconsolidated affiliates       96,232 58,649 233,362 161,340
Operating income       76,224 18,914 179,471 93,506
Interest expense, net       11,766 23,865 35,630 36,658
Debt extinguishment costs         16,887   16,887
Earnings from continuing operations before income taxes       64,458 (21,838) 143,841 39,961
Income tax expense       21,797 (8,566) 46,467 16,687
Net earnings from continuing operations         (13,272)   23,274
Net loss from discontinued operations         3,438   3,048
Net earnings       42,661 (9,834) 97,374 26,322
Less net earnings attributable to noncontrolling interests       0 0 0 0
Net earnings (loss) attributable to AmSurg Corp. shareholders       42,661 (9,834) 97,374 26,322
Preferred stock dividends       (2,264) (2,239) (6,792) (2,239)
Net earnings (loss) attributable to AmSurg Corp. common shareholders       40,397 (12,073) 90,582 24,083
Amounts attributable to AmSurg Corp. common shareholders:              
Earnings (loss) from continuing operations, net of income tax         (15,511)   21,035
Loss from discontinued operations, net of income tax         3,438   3,048
Net earnings (loss) attributable to AmSurg Corp. common shareholders       40,397 (12,073) 90,582 24,083
Guarantor Subsidiaries [Member]              
Condensed Financial Statements, Captions [Line Items]              
Net revenue       339,484 221,013 954,642 221,013
Operating expenses:              
Salaries and benefits       231,769 153,653 671,988 153,653
Supply cost       476 816 1,361 816
Other operating expenses       34,742 19,127 106,452 19,127
Transaction costs       1,837 1,991 4,698 1,991
Depreciation and amortization       14,906 12,320 43,830 12,320
Total operating expenses       283,730 187,907 828,329 187,907
Net gain on deconsolidations       9,112   5,889 3,411
Equity in earnings of unconsolidated affiliates       64,423 48,225 183,519 150,916
Operating income       129,289 81,331 315,721 187,433
Interest expense, net       17,845 14,630 53,223 14,630
Debt extinguishment costs         0   0
Earnings from continuing operations before income taxes       111,444 66,701 262,498 172,803
Income tax expense       15,210 8,051 29,134 8,051
Net earnings from continuing operations         58,650   164,752
Net loss from discontinued operations         0   0
Net earnings       96,234 58,650 233,364 164,752
Less net earnings attributable to noncontrolling interests       0 0 0 0
Net earnings (loss) attributable to AmSurg Corp. shareholders       96,234 58,650 233,364 164,752
Preferred stock dividends       0 0 0 0
Net earnings (loss) attributable to AmSurg Corp. common shareholders       96,234 58,650 233,364 164,752
Amounts attributable to AmSurg Corp. common shareholders:              
Earnings (loss) from continuing operations, net of income tax         58,650   164,752
Loss from discontinued operations, net of income tax         0   0
Net earnings (loss) attributable to AmSurg Corp. common shareholders       96,234 58,650 233,364 164,752
Non-Guarantor Subsidiaries [Member]              
Condensed Financial Statements, Captions [Line Items]              
Net revenue       314,382 280,589 915,791 815,272
Operating expenses:              
Salaries and benefits       78,249 71,846 227,703 208,527
Supply cost       45,182 41,070 132,705 119,748
Other operating expenses       66,522 60,390 196,023 170,496
Transaction costs       0 0 0 0
Depreciation and amortization       8,183 7,729 23,799 22,784
Total operating expenses       198,136 181,035 580,230 521,555
Net gain on deconsolidations       0   (35) 0
Equity in earnings of unconsolidated affiliates       0 0 0 0
Operating income       116,246 99,554 335,526 293,717
Interest expense, net       631 559 1,818 1,618
Debt extinguishment costs         0   0
Earnings from continuing operations before income taxes       115,615 98,995 333,708 292,099
Income tax expense       511 537 1,359 1,064
Net earnings from continuing operations         98,458   291,035
Net loss from discontinued operations         (5,135)   (4,194)
Net earnings       115,104 93,323 332,349 286,841
Less net earnings attributable to noncontrolling interests       55,618 47,257 160,407 139,387
Net earnings (loss) attributable to AmSurg Corp. shareholders       59,486 46,066 171,942 147,454
Preferred stock dividends       0 0 0 0
Net earnings (loss) attributable to AmSurg Corp. common shareholders       59,486 46,066 171,942 147,454
Amounts attributable to AmSurg Corp. common shareholders:              
Earnings (loss) from continuing operations, net of income tax         50,880   151,885
Loss from discontinued operations, net of income tax         (4,814)   (4,431)
Net earnings (loss) attributable to AmSurg Corp. common shareholders       $ 59,486 $ 46,066 $ 171,942 $ 147,454